Urgent Need to Maintain Patient Treatment Rates Drives Technological Advancements in Clinical Laboratory Analyzers Markets.

DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c46503) has announced the addition of Frost & Sullivan's new report: U.S. Clinical Laboratory Analyzer Markets to their offering.

The clinical laboratory analyzers markets comprise various analyzers that perform diagnostic tests to monitor common bodily parameters and diagnose diseases. With these instruments becoming increasingly sophisticated, healthcare institutions are recognizing greater value in them for the improvement of disease management and patient success rates. The resultant escalating demand for quick and accurate results will inflict greater pressure on clinical laboratory operations. As a result, these analyzers are expanding system capabilities and introducing technological advancements to provide comprehensive testing solutions that facilitate efficient, accurate, and streamlined laboratory procedures.

This study evaluates the development of emerging technologies in the U.S. clinical laboratory analyzers markets. It also examines the challenges participants are likely to face in this space and offers strategic recommendations for the same. The study provides an in-depth look into the following market segments: clinical chemistry, immunoassay, integrated, hematology, hemostasis, and blood gas analyzers. In addition, it details the revenues, growth, and market share analysis of these segments.

Despite Laboratory Consolidation and System Replacements, Manufacturers Continue to Provide High-quality Analyzers

Due to saturation, these markets rely on system replacements instead of sale of new equipment to generate revenues; also, laboratory consolidation is a trend that decreases new placements for manufacturers, according to the analyst of this study. To remain competitive, manufacturers need to focus their attention on improvements to instrumentation, including enhancements in automation, integration, throughput, and ease of use.

Despite increasing numbers of leases and reagent rental contracts, expanded menus that add value to laboratories by minimizing maintenance requirements encourage widespread uptake of these analyzers. Also, manufacturers provide instruments that are efficient, accurate, lower costs, and simplify processes to increase productivity of laboratories and thereby encourage demand.

Next-generation Instrumentation with Comprehensive Testing Capabilities Needed to Combat Emergence of Competitive Technologies

Shortage of skilled personnel and advancement in alternative technologies, such as molecular diagnostics analyzers, point-of-care instruments, and home testing devices is causing concern to manufacturers in these mature markets. Although these factors sound challenging, they promote technological enhancements to clinical laboratory analyzer features and testing capabilities, thereby improving the quality of instruments produced. To remain competitive, manufacturers are designing smaller, fully automated, and highly sophisticated systems that are easy to use, provide networking solutions, and facilitate efficient data management.

In future, retaining market share is likely to depend on providing solutions that address customer concerns over staffing shortages, higher testing volumes, space constraints, cost pressures, and workflow management, notes the analyst. Additionally, the clinical laboratory analyzer markets are experiencing a trend toward testing consolidation, which is creating demand for integrated systems with expanded capabilities, thereby securing the future for next-generation laboratory analyzers.

For more information visit http://www.researchandmarkets.com/reports/c46503

Source: Frost & Sullivan